XML 52 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities      
Net income (loss) $ 1,174 $ 2,801 $ (2,249)
Adjustments to reconcile net income (loss) to net cash provided by operating activities      
Depreciation 562 497 579
Amortization of definite-lived intangible assets 313 948 102
Capitalized software amortization 704 813 978
Amortization of deferred financing costs 12 2 92
Change in fair value of contingent consideration 354 (322) 147
Stock-based compensation expense 914 727 883
Equity loss on investment in GSE-UNIS Simulation Technology Co. Ltd. 238 41 13
Loss on derivative instruments 121 68 913
Changes in assets and liabilities      
Contract receivables (3,331) (2,099) (903)
Prepaid expenses and other assets 1,379 (1,494) (922)
Accounts payable, accrued compensation and accrued expenses 1,403 (855) 932
Billings in excess of revenue earned 792 856 1,669
Accrued warranty reserves (193) 620 407
Other liabilities (702) (1,035) (209)
Net cash provided by operating activities 3,740 1,568 2,432
Cash flows from investing activities      
Capital expenditures (1,551) (520) (519)
Capitalized software development costs (1,315) (838) (903)
Investment in GSE-UNIS Simulation Technology Co. Ltd. (469) (456) (587)
Acquisitions, net of cash acquired 0 (830) (549)
Restrictions of cash as collateral under letters of credit (1,777) (5,668) 0
Release of cash as collateral under letters of credit 4,244 1,717 1,135
Drawdown of cash collateral on Emirates Simulation Academy, LLC line of credit 0 (78) (294)
Proceeds from sale/leaseback transaction 0 0 377
Net cash used in investing activities (868) (6,673) (1,340)
Cash flows from financing activities      
Proceeds from issuance of common stock 272 143 176
Treasury stock purchases (531) (1,649) 0
Payments of the liability-classified contingent consideration arrangements (845) (167) 0
Release of cash for credit facility collateral 0 600 0
Deferred financing costs 0 (24) (82)
Net cash provided by (used in) financing activities (1,104) (1,097) 94
Effect of exchange rate changes on cash 292 (49) 121
Net increase (decrease) in cash and cash equivalents 2,060 (6,251) 1,307
Cash and cash equivalents at beginning of year 20,326 26,577 25,270
Cash and cash equivalents at end of period 22,386 20,326 26,577
Non-cash financing activities      
Issuance of 122,617 shares of common stock to acquire TAS Holdings Ltd. $ 0 $ 0 $ 683